Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7484159rdf:typepubmed:Citationlld:pubmed
pubmed-article:7484159lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:7484159lifeskim:mentionsumls-concept:C0026032lld:lifeskim
pubmed-article:7484159lifeskim:mentionsumls-concept:C0017237lld:lifeskim
pubmed-article:7484159lifeskim:mentionsumls-concept:C0026259lld:lifeskim
pubmed-article:7484159lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:7484159lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:7484159pubmed:issue7lld:pubmed
pubmed-article:7484159pubmed:dateCreated1995-11-30lld:pubmed
pubmed-article:7484159pubmed:abstractTextLung targeting gelatin microspheres of mitoxantrone (DHAQ) were prepared by a two-step method. The diameter of 87.36% of the DHAQ gelatin microspheres (DHAQ-GMS) was in the range of 5.1 to 25.0 microns. Release of the drug from the DHAQ-GMS in vitro became much slower and its t1/2 was 4 times longer than that of pure DHAQ. The characteristic peak of heat absorption on the differential thermal analysis curve was at 133 degrees C and almost no change was observed after the DHAQ-GMS were stored for 3 months at 37 degrees C (relative humidity 75%). The distribution test in vivo in mice indicated that the lung targeting effect of the DHAQ-GMS was obvious and that the targeting efficiency of the lung compared to other organs and blood increased 3 to 35 times. Kinetic behavior of the drug in mouse lung could be described by one open compartment model, and the average residual time increased by 10 h.lld:pubmed
pubmed-article:7484159pubmed:languagechilld:pubmed
pubmed-article:7484159pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7484159pubmed:citationSubsetIMlld:pubmed
pubmed-article:7484159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7484159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7484159pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7484159pubmed:statusMEDLINElld:pubmed
pubmed-article:7484159pubmed:issn0513-4870lld:pubmed
pubmed-article:7484159pubmed:authorpubmed-author:WangJ HJHlld:pubmed
pubmed-article:7484159pubmed:authorpubmed-author:LoHHlld:pubmed
pubmed-article:7484159pubmed:authorpubmed-author:PazR RRRlld:pubmed
pubmed-article:7484159pubmed:authorpubmed-author:YUP MPMlld:pubmed
pubmed-article:7484159pubmed:authorpubmed-author:ZhangZ RZRlld:pubmed
pubmed-article:7484159pubmed:issnTypePrintlld:pubmed
pubmed-article:7484159pubmed:volume30lld:pubmed
pubmed-article:7484159pubmed:ownerNLMlld:pubmed
pubmed-article:7484159pubmed:authorsCompleteYlld:pubmed
pubmed-article:7484159pubmed:pagination549-55lld:pubmed
pubmed-article:7484159pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:meshHeadingpubmed-meshheading:7484159-...lld:pubmed
pubmed-article:7484159pubmed:year1995lld:pubmed
pubmed-article:7484159pubmed:articleTitle[Studies on lung targeting gelatin microspheres of mitoxantrone].lld:pubmed
pubmed-article:7484159pubmed:affiliationSchool of Pharmacy, West China University of Medical Sciences, Chengdu.lld:pubmed
pubmed-article:7484159pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7484159pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:7484159pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed